Literature DB >> 15134803

The regulation of aldosterone synthase expression.

Mary H Bassett1, Perrin C White, William E Rainey.   

Abstract

Aldosterone, the primary human mineralocorticoid, is a major regulator of intravascular volume and blood pressure. The capacity of the adrenal gland to produce aldosterone is controlled, in large part, by the regulated transcription of CYP11B2, the gene encoding aldosterone synthase. Aldosterone synthase is responsible for the conversion of 11-deoxycorticosterone to aldosterone and is expressed only within the zona glomerulosa of the adrenal cortex. The development of new systems for in vitro studies of expression has helped define molecular mechanisms that regulate this enzyme and thus the capacity of the adrenal gland to produce aldosterone. Both potassium and angiotensin II (ANG II) increase intracellular calcium levels, which regulate expression of CYP11B2 through transcription factors that interact with defined sites in the 5'-flanking region of the gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134803     DOI: 10.1016/j.mce.2003.10.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  52 in total

Review 1.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

2.  Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.

Authors:  Mutsa Seremwe; Rick G Schnellmann; Wendy B Bollag
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

Review 3.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

4.  3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.

Authors:  Sachiko Konosu-Fukaya; Yasuhiro Nakamura; Fumitoshi Satoh; Saulo J A Felizola; Takashi Maekawa; Yoshikiyo Ono; Ryo Morimoto; Kazue Ise; Ken-Ichiro Takeda; Koshin Katsu; Fumiyoshi Fujishima; Atsuko Kasajima; Mika Watanabe; Yoichi Arai; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Masao Doi; Hitoshi Okamura; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2014-10-22       Impact factor: 4.102

Review 5.  Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.

Authors:  Francisco V Sepúlveda; L Pablo Cid; Jacques Teulon; María Isabel Niemeyer
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 6.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

7.  Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca2+ overload in H295R cells.

Authors:  Jinghui Lei; Suli Zhang; Pengli Wang; Yang Liao; Jingwei Bian; Xiaochen Yin; Ye Wu; Lina Bai; Feng Wang; Xiaoli Yang; Huirong Liu
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

8.  NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells.

Authors:  Senthilkumar B Rajamohan; Gayatri Raghuraman; Nanduri R Prabhakar; Ganesh K Kumar
Journal:  Antioxid Redox Signal       Date:  2012-03-02       Impact factor: 8.401

9.  Regulation of adrenal aldosterone production by serine protease prostasin.

Authors:  Takehiro Ko; Yutaka Kakizoe; Naoki Wakida; Manabu Hayata; Kohei Uchimura; Naoki Shiraishi; Taku Miyoshi; Masataka Adachi; Shizuka Aritomi; Tomoyuki Konda; Kimio Tomita; Kenichiro Kitamura
Journal:  J Biomed Biotechnol       Date:  2010-03-02

Review 10.  The effect of RAAS blockade on the progression of diabetic nephropathy.

Authors:  Sara S Roscioni; Hiddo J Lambers Heerspink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2013-12-03       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.